Abbvie raises sales outlook of two new drugs to more than $17.5 billion in 2025
...(Reuters) - AbbVie Inc on Tuesday raised its sales forecast......…
152,880€
1,08%
Echtzeit-Aktienkurs ABBVIE
Bid:
Ask:
Nachrichten zur ABBVIE Aktie
UPDATE 1-Abbvie raises sales outlook of two new drugs to more than $17.5 bln in 2025
...(Adds details on forecast, background)
Jan 10 (Reuters) - AbbVie Inc......…
AbbVie seeks mRNA technology in pact with Anima Biotech
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abbvie expects sales of two drugs to exceed $21 bln in 2027
...Jan 10 (Reuters) - AbbVie said on Tuesday it
expects combined peak......…
AbbVie, Anima Biotech to Collaborate on mRNA Biology Modulators >ABBV
AbbVie, Anima Biotech to Collaborate on mRNA Biology Modulators >ABBV...…
Form 8-K AbbVie Inc. For: Jan 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
$121 Billion Worldwide Cytokine Industry to 2027 - Featuring AbbVie, Abcam, Amgen and Applied Biological Materials Among Others
DUBLIN, Jan. 10, 2023 /PRNewswire/ -- The "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report…
Antibiotics market to grow by 5.11% Y-O-Y from 2022 to 2023: Rising prevalence of infectious diseases will drive growth - Technavio
NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Antibiotics market insights - Vendors: 15+, Including Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals…
AbbVie cuts earnings forecast due to milestone payments
AbbVie Inc. lowered its outlook for the quarter and year late Friday for research and development expenses and milestone payments…
AbbVie expects IPR&D and milestones expense to impact Q4, full-year 2022 results
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie (ABBV) Humira Biosimilars Require Complex Math From CVS
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie, Immunome Collaborate To Discover Multiple Novel Oncology Targets
WASHINGTON (dpa-AFX) - AbbVie (ABBV) and Immunome Inc. (IMNM) have collaborated to discover up to 10 novel antibody-target pairs arising…
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
- Multi-year collaboration to identify up to 10 novel target-antibody pairs leveraging Immunomes Discovery Engine - Immunome to receive $30M…
CytomX Therapeutics Provides Business Update and Outlines 2023 Company Priorities
- CX-2029 (CD71 conditionally activated ADC) continued to demonstrate encouraging anti-cancer activity in squamous tumors in the now completed Phase…
AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call
NORTH CHICAGO, Ill., Jan. 5, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday,…
AbbVie (ABBV) Gains As Market Dips: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $162.38, marking a +0.48% move from the previous day....…
ADC Therapeutics appoints AbbVie executive Mohamed Zaki as chief medical officer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cashing out in biotech in 2022: On-target predictions for AbbVie, Vertex and Genmab
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Samsung Bioepis speeding up US launch of Humira biosimilar
Samsung Bioepis has brought forward its interchangeability study of Hadlima to speed up its launch in the US market, according…
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could…
The Zacks Analyst Blog Highlights AbbVie, PepsiCo, Oracle, HSBC Holdings and The Progressive
AbbVie, PepsiCo, Oracle, HSBC Holdings and The Progressive are part of the Zacks top Analyst Blog....…
AbbVie (ABBV) Stock Moves -0.07%: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $162.99, moving -0.07% from the previous trading session....…
Top Analyst Reports for AbbVie, PepsiCo & Oracle
Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), PepsiCo, Inc. (PEP) and Oracle…
$1000 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
read more...…
If You Invested $25,000 in AbbVie In 2020, This Is How Much You Would Have Today
In May 2020, the company closed on its acquisition of Botox maker Allergan....…
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $160.58, moving -0.56% from the previous trading session....…
Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Herpes treatment market insights - Vendors: 15+, including AbbVie Inc., AiCuris Anti infective…
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could…
AbbVie (ABBV) Vraylar Gets FDA Nod for Major Depressive Disorder
FDA approves AbbVies (ABBV) Vraylar (cariprazine) for its fourth indication - the adjunctive treatment of patients with MDD....…
Time to Buy Eli Lilly (LLY) and AbbVie (ABBV) Stock for 2023?
AbbVies valuation, in particular, makes it a potentially strong candidate for 2023, while Eli Lillys growth could support its stock…
AbCellera (ABCL) to Develop New Antibody Therapies With AbbVie
AbCellera (ABCL) inks a strategic collaboration with AbbVie to develop new antibody therapies across multiple indications. ABCL shares rise....…
AbbVie submits sNDA for Linzess for constipation in children
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Submits SNDA For Linaclotide For Treatment Of Children, Adolescents
WASHINGTON (dpa-AFX) - AbbVie (ABBV) has submitted a supplemental New Drug Application for linaclotide or LINZESS to the FDA for…
AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
If approved, linaclotide would be the first prescription therapy for functional constipation in children and adolescents 6 to 17 years…
Why Pfizer Stock Is Riskier Than AbbVie
Pfizer has a lot more revenue at risk over the next several years than AbbVie does....…
AbbVie to leave top pharma industry group
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie to leave leading U.S. drug industry trade group
...(Reuters) - AbbVie Inc is leaving Pharmaceutical Research... confirmed Reuters about the exits in the Politico…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…